Actinogen Medical Limited ATGGF
Set alert
0.03 USD 0.00 0.00%
At close · Oct 30
0.035 Day range 0.035
0.0008 52-week range 0.06
- YTD
- -26.75%
- 1 year
- +17.20%
- Open
- 0.035
- Prev close
- 0.0293
- Mkt cap
- 113.51M
- Vol
- 10.00K
- Avg vol
- 15.35K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.035
- High
- 0.035
2Y chart
Signals (34)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| RSI: Oversold | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| RSI: Oversold | Apr 23, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Mar 31, 2026 | 7 months ago |
| SMA: Bullish | Mar 25, 2026 | 7 months ago |
| RSI: Overbought | Mar 25, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| RSI: Oversold | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 5, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 14, 2025 | 11 months ago |
| RSI: Overbought | Nov 14, 2025 | 11 months ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| RSI: Oversold | Sep 10, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 17, 2025 | 1 year ago |
| SMA: Bullish | Jun 24, 2025 | 1 year ago |
| RSI: Overbought | Jun 24, 2025 | 1 year ago |
| MACD: Buy Signal | May 29, 2025 | 1 year ago |
| RSI: Oversold | May 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 4, 2025 | 1 year ago |
| RSI: Overbought | Nov 27, 2024 | 1 year ago |
News
- Actinogen Medical nears key XanaMIA trial readout - ICYMI
- Actinogen Medical enters ‘database lock' to process XanaMIA' data and confirm findings
- Actinogen Medical closes September quarter with XanaMIA readout in sight
- Actinogen's Xanamem trial hits key milestone ahead of results - ICYMI
- Actinogen Medical completes final XanaMIA patient visit; November Alzheimer's trial results on track
- Dow slips, Nasdaq edges lower as August ends in green
- Nvidia's $12.9bn Hugging Face swoop is really about filling the cloud capacity it has underwritten
- UBS says bond market relief from falling yields will not offset deeper structural pressures
- Riot Platforms $9.1B AI deal fuels speculation around Anthropic IPO
- Traders see little chance of Hormuz shipping recovery by end of August
Your note
Sign in to keep a note on ATGGF — it syncs with the Stock Master app.